TRAIP and breast carcinoma: Since overexpression of TRAIP has been reported in basal cell carcinomas [19], breast cancer [5, 52] and melanomas (unpublished results), targeting TRAIP or its substrates may provide new possibilities for therapeutic interventions in tumors.